Generally, tirzepatide is recommended for individuals who have a Body Mass Index (BMI) of 27 or higher, meaning they’re classified as overweight or obese. In addition to this, those with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or heart disease, may also be considered for tirzepatide treatment. Before starting tirzepatide, it’s important for patients to undergo a thorough medical evaluation to determine whether this medication is appropriate for them. Those who have a history of pancreatitis, thyroid tumors, severe gastrointestinal problems, or diabetic ketoacidosis may not be suitable candidates for tirzepatide. Furthermore, women who are pregnant or breastfeeding shouldn’t take this medication because its effects on fetal development are still unknown.